Item 4 — Purpose of Transaction
In connection with the Financing, on September 23, 2026, the Trust and the Company entered into a Board Rights Agreement, pursuant to which the size of the Company's board of directors is to be fixed at five directors, with the Trust having the right to designate two persons to be appointed to the board of directors (the "Trust Directors"). Philip Barach, a trustee of the Trust, was appointed to the Company's board of directors as a designee of the Trust under the Board Rights Agreement on September 24, 2026. In addition, the reasonable approval of the Trust Directors must be obtained for the appointment of an independent director by the other directors, and the Company's ability spend the proceeds received in the Financing will be limited until the Company's board of directors is composed of such persons as are required by the Board Rights Agreement. The Reporting Persons expect to evaluate on an ongoing basis the Company's financial condition and prospects and their interest in, and intentions with respect to, the Company and their investment in the securities of the Company, which review may be based on various factors, including the Company's business and financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Company's securities in particular, as well as other developments and other investment opportunities, which, if effected, could result in, among other things, any of the matters identified in Items 4(a)-(j) of Schedule 13D. Accordingly, the Reporting Persons reserve the right to change their intentions and develop plans or proposals at any time, as they deem appropriate. In particular, the Reporting Persons may at any time and from time to time, (i) in the open market, in privately negotiated transactions or otherwise, acquire additional Class A Common Stock or other securities of the Company, including acquisitions from affiliates of the Reporting Persons; (ii) dispose or transfer of all or a portion of the securities of the Company, including the Class A Common Stock, that the Reporting Persons now own or may hereafter acquire to any person or entity, including dispositions to affiliates of the Reporting Persons; (iii) enter into derivative transactions with institutional counterparties with respect to the Company's securities; (iv) cause or seek to cause the Company or any of its subsidiaries to acquire all or a portion of another person's assets or business, including acquisitions from affiliates of the Reporting Persons; (v) cause or seek to cause the Company or any of its subsidiaries to enter into one or more acquisitions, business combinations or mergers or to sell, transfer or otherwise dispose of all or any portion of its assets or business to any person or entity, including acquisitions, business combinations, mergers, sales, transfers and other dispositions with or to affiliates of the Reporting Persons; (vi) restructure the Company's or any of its subsidiaries' capitalization, indebtedness or holding company arrangements; (vii) make personnel changes to the present management of the Company deemed necessary or desirable; (viii) change the identity of the directors of the Company; (ix) make or propose any other material change in the Company's or any of its subsidiaries' corporate structure or business; or (x) engage in communications with one or more stockholders, officers or directors of the Company and other persons regarding any of the matters described in clauses (i) through (ix) above.